Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Exovitra LLC holds a patent portfolio in the Medical Devices & Mechanical Engineering technology area. There is 1 pending office action associated with this portfolio. Prosecution is currently limited to 1 distinct examiner and 1 distinct art unit. This structure indicates that the company's current legal focus is concentrated on a specific point of examination. The nature of the 1 pending office action suggests a streamlined prosecution phase for the applicant. This centralized activity minimizes the need for complex coordination across different technical divisions.
The busiest examiner, OU, JING RUI, is currently processing 1 pending office action. This represents the total pending workload for the portfolio. Because all activity is funneled through OU, JING RUI, the outcome of the current prosecution phase depends on this examiner's findings. The involvement of 1 distinct art unit means that the technical classification of the work is consistent across the pending portfolio. Practitioners can focus their resources on addressing the specific technical requirements of this 1 distinct art unit and OU, JING RUI.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OU, JING RUI | 1 | 53.5% | +51.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17971947 | METHODS AND SYSTEMS FOR TREATMENT OF ANEURYSMS | OU, JING RUI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17971947 | METHODS AND SYSTEMS FOR TREATMENT OF ANEURYSMS | OU, JING RUI | — |
| Art Unit | Apps |
|---|---|
| 3771 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17971947 | METHODS AND SYSTEMS FOR TREATMENT OF ANEURYSMS | OU, JING RUI | 3771 | §102§103§112 | Final Rejection | — | Pending | Oct 24, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialExovitra LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jing Rui Ou has the most, with 1 of Exovitra LLC's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
